Neurological manifestations associated with COVID-19 vaccine

Garg, 2022, Spectrum of neurological complications following COVID-19 vaccination, Neurol Sci, 43, 3, 10.1007/s10072-021-05662-9 Ismail, 2022, A systematic review of cases of CNS demyelination following COVID-19 vaccination, J Neuroimmunol, 362, 10.1016/j.jneuroim.2021.577765 Cauchi, 2022, Interpretation of vaccine associated neurological adverse events: a methodological and historical review, J Neurol, 269, 493, 10.1007/s00415-021-10747-8 Lu, 2021, The potential neurological effect of the COVID-19 vaccines: A review, Acta Neurol Scand, 144, 3, 10.1111/ane.13417 Noseda, 2021, Reporting of acute inflammatory neuropathies with covid-19 vaccines: Subgroup disproportionality analyses in vigibase, Vaccines, 9, 1022, 10.3390/vaccines9091022 Patone, 2021, Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection, Nat Med, 27, 2144, 10.1038/s41591-021-01556-7 Voysey, 2021, Safety and efficacy of the ChAdOx1 nCoV-19 vaccine ( AZD1222 ) against SARS-CoV-2 : an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK, Lancet, 397, 99, 10.1016/S0140-6736(20)32661-1 Baden, 2021, Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine, N Engl J Med, 384, 403, 10.1056/NEJMoa2035389 Fernando, 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577 Sadoff, 2021, Interim results of a phase 1–2a trial of Ad26.COV2.S Covid-19 vaccine, N Engl J Med, 384, 1824, 10.1056/NEJMoa2034201 Goepfert, 2021, Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19, N Engl J Med, 384, 2187, 10.1056/NEJMoa2101544 Goulart Corrêa, 2021, Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?, Clin Imaging, 80, 348, 10.1016/j.clinimag.2021.08.021 Page, 2021, The PRISMA 2020 statement: An updated guideline for reporting systematic reviews, BMJ, 372 Krzywicka, 2021, Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency, Eur J Neurol, 28, 3656, 10.1111/ene.15029 Van De Munckhof, 2022, Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS- ­ 2 vaccination, Eur J Neurol, 29, 339, 10.1111/ene.15113 Sato, 2021, Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database, Int J Infect Dis, 111, 310, 10.1016/j.ijid.2021.08.071 García-Grimshaw, 2021, Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study, Clin Immunol, 229, 10.1016/j.clim.2021.108786 García-Grimshaw, 2021, Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study, Vaccine, 39, 6975, 10.1016/j.vaccine.2021.10.058 García-Grimshaw, 2021, Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine, Clin Immunol, 230, 10.1016/j.clim.2021.108818 Bikdeli, 2021, Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19, J Am Coll Cardiol, 78, 408, 10.1016/j.jacc.2021.06.001 Koh, 2021, Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines, J Neurol Sci, 430, 10.1016/j.jns.2021.120030 Perry, 2021, Cerebral venous thrombosis after vaccination against COVID-19 in the UK: Multicentre cohort study, Lancet, 398, 1147, 10.1016/S0140-6736(21)01608-1 Schulz, 2021, COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany, Ann Neurol, 90, 627, 10.1002/ana.26172 Lechien, 2021, COVID-19: Post-vaccine Smell and Taste Disorders: Report of 6 Cases, Ear, Nose Throat J, 10.1177/01455613211033125 Ghosh, 2021, Focal onset non-motor seizure following COVID-19 vaccination: A mere coincidence?, Diabetes Metab Syndr Clin Res Rev, 15, 1023, 10.1016/j.dsx.2021.05.003 Thakur, 2021, Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons from the Past to Inform the Present, Neurology, 97, 767, 10.1212/WNL.0000000000012703 Sharifian-Dorche, 2021, Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review, J Neurol Sci, 428, 10.1016/j.jns.2021.117607 Mehta, 2021, Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination – A report of two UK cases, Brain Behav Immun, 95, 514, 10.1016/j.bbi.2021.04.006 Kaulen, 2022, Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series, Eur J Neurol, 29, 555, 10.1111/ene.15147 Frontera, 2022, Neurological Events Reported after COVID-19 Vaccines : An Analysis of Vaccine Adverse Event Reporting System, Ann Neurol, 91, 756, 10.1002/ana.26339 Wang, 2021, COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism, QJM An Int J Med, 114, 506, 10.1093/qjmed/hcab185 Zuhorn, 2021, Postvaccinal Encephalitis after ChAdOx1 nCov-19, Ann Neurol, 90, 506, 10.1002/ana.26182 García-Estrada, 2021, Optic neuritis after COVID-19 vaccine application, Clin Exp Neuroimmunol, 00, 1 Tan, 2021, Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: A case report, BMC Neurol, 21, 395, 10.1186/s12883-021-02427-x Chen, 2021, Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19, Neurol Sci, 42, 3537, 10.1007/s10072-021-05427-4 da Silva, 2021, Guillain–Barré syndrome after coronavirus disease 2019 vaccine: A temporal association, Clin Exp Neuroimmunol, 00, 1 Matarneh, 2021, COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect, Clin Case Reports, 9, 10.1002/ccr3.4756 Nishiguchi, 2021, Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination, BMC Neurol, 21, 452, 10.1186/s12883-021-02489-x Rossetti, 2021, Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report, J Emerg Med, 61, e141, 10.1016/j.jemermed.2021.07.062 Čenščák, 2021, Guillan-Barré Syndrome after First Vaccination Dose against COVID-19 : Case Report, Acta Medica Cordoba, 64, 183 Dang, 2021, Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination, BMJ Case Rep, 14, 10.1136/bcr-2021-246701 Osowicki, 2021, Guillain-Barré Syndrome in an Australian State Using Both mRNA and Adenovirus-Vector SARS-CoV-2 Vaccines, Ann Neurol, 90, 856, 10.1002/ana.26218 Min, 2021, Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature, J Neuroimmunol, 359, 10.1016/j.jneuroim.2021.577691 Fan, 2021, Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination: A black swan event, Am J Hematol, 96, E357, 10.1002/ajh.26272 Graf, 2021, Immediate high‑dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars‑Covid‑19‑adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein t, J Neurol, 268, 4483, 10.1007/s00415-021-10599-2 Ikenberg, 2021, Cerebral venous sinus thrombosis after 19 vaccination with a misleading first cerebral MRI scan, Stroke Vasc Neurol, 6, 10.1136/svn-2021-001095 Kenda, 2021, Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke, J Stroke Cerebrovasc Dis, 30, 10.1016/j.jstrokecerebrovasdis.2021.106072 Kotal, 2021, A rare case of vaccine-induced immune thrombosis and thrombocytopenia and approach to management, Surg Neurol Int, 12, 10.25259/SNI_689_2021 Maramattom, 2021, Cerebral venous sinus thrombosis after ChAdOx1 vaccination: The first case of definite thrombosis with thrombocytopenia syndrome from India, BMJ Case Rep, 14, 10.1136/bcr-2021-246455 Schultz, 2021, Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination, N Engl J Med, 384, 2124, 10.1056/NEJMoa2104882 Sorensen, 2021, A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2, Blood Adv, 5, 2569, 10.1182/bloodadvances.2021004904 Tiede, 2021, Prothrombotic immune thrombocytopenia after COVID-19 vaccination, Blood, 138, 350, 10.1182/blood.2021011958 Yagi, 2022, Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination, Neurol Sci, 43, 41, 10.1007/s10072-021-05714-0 Bayas, 2021, Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination, Lancet, 397, e11, 10.1016/S0140-6736(21)00872-2 Blauenfeldt, 2021, Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector- based COVID- 19 vaccine, J Thromb Haemost, 19, 1771, 10.1111/jth.15347 Mélo, 2021, Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccinatio: A case report, Acta Neurol Scand, 144, 717, 10.1111/ane.13505 Maniscalco, 2021, Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report, Front Neurol, 12, 10.3389/fneur.2021.721502 Mirmosayyeb, 2021, Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report, Hum Vaccines Immunother, 17, 4099, 10.1080/21645515.2021.1971920 Miyaue, 2022, A Case of Refractory Longitudinally Extensive Transverse Myelitis after Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in a Japanese Man, Intern Med, 61, 739, 10.2169/internalmedicine.8747-21 Ozgen, 2021, Acute disseminated encephalomyelitis ‑ like presentation after an inactivated coronavirus vaccine, Acta Neurol Belg, 121, 1089, 10.1007/s13760-021-01699-x Pagenkopf, 2021, A case of longitudinally extensive transverse myelitis following vaccination against Covid-19, J Neuroimmunol, 358, 10.1016/j.jneuroim.2021.577606 Permezel, 2022, Acute disseminated encephalomyelitis (ADEM) following recent Oxford/AstraZeneca COVID-19 vaccination, Forensic Sci Med Pathol, 1, 74, 10.1007/s12024-021-00440-7 Sepahvand, 2022, Cervical longitudinally extensive myelitis after vaccination with inactivated virus-based COVID-19 vaccine, Radiol Case Reports, 17, 303, 10.1016/j.radcr.2021.10.053 Shimizu, 2021, An 88-year-old woman with acute disseminated encephalomyelitis following messenger ribonucleic acid-based COVID-19 vaccination, eNeurologicalSci, 25, 10.1016/j.ensci.2021.100381 Takenaka, 2021, Myeloperoxidase anti-neutrophil cytoplasmic antibody positive optic perineuritis after mRNA coronavirus disease-19 vaccine, QJM An Int J Med, 0, 1 Toljan, 2022, New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure, J Neuroimmunol, 362, 10.1016/j.jneuroim.2021.577785 Şimşek Erdem, 2021, Acute transverse myelitis after inactivated COVID-19 vaccine, Ideggyogy Sz, 57, 273, 10.18071/isz.74.0273 Vegezzi, 2021, Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?, J Neuroimmunol, 359, 10.1016/j.jneuroim.2021.577686 Vogrig, 2021, Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination, Clin Neurol Neurosurg, 208, 10.1016/j.clineuro.2021.106839 Fujikawa, 2021, Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine, Cureus, 13 Ghosh, 2022, ‘Wine Glass’ sign following COVID-19 vaccination in a previously healthy adult, Neurología, 10.1016/j.nrl.2022.01.003 Havla, 2022, First manifestation of multiple sclerosis after immunization with the Pfizer ‑ BioNTech COVID ‑ 19 vaccine, J Neurol, 269, 55, 10.1007/s00415-021-10648-w Hsiao, 2021, Acute Transverse Myelitis after COVID-19 Vaccination, Medicina (Kaunas), 57 Kania, 2021, Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2, Ann Clin Transl Neurol, 8, 2000, 10.1002/acn3.51447 Khayat-Khoei, 2022, COVID-19 mRNA vaccination leading to CNS inflammation: A case series, J Neurol, 269, 1093, 10.1007/s00415-021-10780-7 Malhotra, 2021, COVID-19 vaccination-associated myelitis, QJM An Int J Med, 114, 591, 10.1093/qjmed/hcab069 Takata, 2021, A case report of ChAdOx1 nCoV-19 vaccine–associated encephalitis, BMC Neurol, 21, 485, 10.1186/s12883-021-02517-w Torrealba-Acosta, 2021, Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine, BMJ Case Rep, 14, 10.1136/bcr-2021-243173 Chan, 2022, Aseptic meningitis after BNT-162b2 COVID-19 vaccination, Brain, Behav Immun - Heal, 19 Saito, 2021, Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine, Neurol Sci, 42, 4433, 10.1007/s10072-021-05543-1 Dalwadi, 2021, Axonal-Variant Guillian-Barre Syndrome Temporally Associated With mRNA-Based Moderna SARS-CoV-2 Vaccine, Cureus, 13 Kanabar, 2021, Guillain ‐ Barré syndrome presenting with facial diplegia following COVID ‐ 19 vaccination in two patients, BMJ Case Rep, 14, 10.1136/bcr-2021-244527 McKean, 2021, Guillain-Barré syndrome after COVID-19 vaccination, BMJ Case Rep, 14, 10.1136/bcr-2021-244125 Oo, 2021, AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?, J Neuroimmunol, 360, 10.1016/j.jneuroim.2021.577719 Patel, 2021, Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1, BMJ Case Rep, 14, 1, 10.1136/bcr-2021-242956 Rao, 2021, A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine, J Community Hosp Intern Med Perspect, 11, 597, 10.1080/20009666.2021.1954284 Trimboli, 2021, Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine, Neurol Sci, 42, 4401, 10.1007/s10072-021-05523-5 Tutar, 2021, A variant of guillain-barre syndrome after sars-cov-2 vaccination: Amsan, Ideggyogy Sz, 74, 286, 10.18071/isz.74.0286 Alessandro, 2021, A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV ‑ 19 vaccine, Neurol Sci, 19, 4747 Cellina, 2022, Left Bell’s palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report, Clin Imaging, 82, 1, 10.1016/j.clinimag.2021.10.010 Manea, 2022, Multiple cranial nerve palsies following COVID- ­ Case report, Acta Neurol Scand, 145, 257, 10.1111/ane.13548 Obermann, 2021, Bell’s palsy following COVID-19 vaccination with high CSF antibody response, Neurol Sci, 42, 4397, 10.1007/s10072-021-05496-5 Kim, 2021, Leg paralysis after AstraZeneca COVID-19 vaccination diagnosed as neuralgic amyotrophy of the lumbosacral plexus : a case report, J Int Med Res, 49, 1, 10.1177/03000605211056783 Mahajan, 2021, Parsonage Turner syndrome after COVID-19 vaccination, Muscle Nerve, 64, 3, 10.1002/mus.27255 Vitturi, 2021, Parsonage–Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: A case report and review of the literature, J Med Case Rep, 15, 589, 10.1186/s13256-021-03176-8 Ercoli, 2021, Functional neurological disorder after COVID-19 vaccination, Neurol Sci, 42, 3989, 10.1007/s10072-021-05504-8 Fukuoka, 2021, Oral Herpes Zoster Infection Following COVID-19 Vaccination: A Report of Five Cases Case Presentation, Cureus, 13 Iwanaga, 2022, A narrative review and clinical anatomy of herpes zoster infection following COVID-19 vaccination, Clin Anat, 35, 45, 10.1002/ca.23790